Matthias Klinger

Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia

S. Chevret, E. Becht, V. Boeva, 2017, Leukemia.

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

G. Zugmaier, H. Horst, R. Bargou, 2014, Blood Cancer Journal.